Pure Global
Disease/Condition
719 Clinical Trials
10+ Countries

Lymphoma Clinical Trials Database - Free Access to 719 Studies

Access comprehensive clinical trial information for Lymphoma through Pure Global AI's free database. This collection includes 719 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 51 trials are actively recruiting participants.

Research for Lymphoma is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include M.D. Anderson Cancer Center and Alliance for Clinical Trials in Oncology. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
Phase 2
318
N/A
132
Phase 3
87
Phase 1
84
Early Phase 1
72
By Status
Completed
404
Unknown
98
Terminated
71
Recruiting
51
Withdrawn
35
Top Countries
United States of America356
China55
United Kingdom28
France21
Canada,United States of America17
Top Sponsors
M.D. Anderson Canc...63
Alliance for Clini...31
Memorial Sloan Ket...26
SWOG Cancer Resear...24
Northwestern Unive...18
Recent Trials
Latest clinical trials for Lymphoma
NCT06294652
Recruiting

AGMT Austrian Lymphoma Registry

Arbeitsgemeinschaft medikament...Austria
NCT06218602
Phase 2
Recruiting

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

M.D. Anderson Cancer CenterUnited States of America
NCT06106776
Not yet recr...

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Fondazione Policlinico Univers...
NCT06070246
Not yet recr...

Navigating the Clinical Research Process for Lymphoma

Power Life Sciences Inc.United States of America
NCT06084936
Phase 3
Recruiting

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Hoffmann-La RocheChina,Italy,South Korea,Spain,Taiwan,United States of America
NCT06049134
Phase 4
Recruiting

Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy

M.D. Anderson Cancer CenterUnited States of America
NCT06026995
Phase 4
Recruiting

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

Chongqing University Cancer Ho...China
NCT06010680
Phase 1
Recruiting

A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers

Jiangsu HengRui Medicine Co., ...China
NCT05982223
Recruiting

Integrative Medicine in Lymphoma Survivors

Bnai Zion Medical CenterIsrael
NCT06067048
Phase 2
Not yet recr...

Zanubrutinib in Primary Cold Agglutinin Disease

Stichting Hemato-Oncologie voo...Belgium,Denmark,Netherlands,Norway
NCT05948033
Phase 1/2
Recruiting

CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma

Chinese PLA General HospitalChina
NCT05952804
Phase 2
Not yet recr...

IVIG for Infection Prevention After CAR-T-Cell Therapy

Fred Hutchinson Cancer CenterUnited States of America
NCT05929612
Phase 2
Recruiting

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

M.D. Anderson Cancer CenterUnited States of America
NCT05891821
Phase 2
Not yet recr...

Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)

Immune Oncology Research Insti...Armenia
NCT05834751
Not yet recr...

the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma

Ou Bai, MD/PHDChina
NCT06047626
Not yet recr...

Living Well With Lymphoma

University of Michigan Rogel C...
NCT05813132
Recruiting

BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation

Rehab WeridaEgypt
NCT05737628
Phase 1
Not yet recr...

First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228

Byondis B.V.
NCT05692050
No longer av...

Expanded Access to Epcoritamab

AbbVie
NCT05683171
Phase 1/2
Not yet recr...

A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma

M.D. Anderson Cancer CenterUnited States of America
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Lymphoma Research

Pure Global AI provides free access to 719 clinical trials studying Lymphoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include M.D. Anderson Cancer Center, Alliance for Clinical Trials in Oncology, Memorial Sloan Kettering Cancer Center, among others.

Quick Facts
Total Trials719
Countries10+
Sponsors10+
Recruiting51